We are live on ! Find out more
CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

Back to rankings

86 hedge funds and large institutions have $131M invested in Cascadian Therapeutics, Inc. in 2014 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 26 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more call options, than puts

Call options by funds: $2.1M | Put options by funds: $686K

200% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 6

20% more capital invested

Capital invested by funds: $110M → $131M (+$21.7M)

16% more funds holding

Funds holding: 74 → 86 (+12)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 26

Holders
86
Holders Change
+12
Holders Change %
+16.22%
% of All Funds
2.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
18
Increased
26
Reduced
26
Closed
6
Calls
$2.1M
Puts
$686K
Net Calls
+$1.42M
Net Calls Change
-$124K

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$4.59M
2
BI
BVF Inc
California
+$2.52M
3
State Street
State Street
Massachusetts
+$1.85M
4
BIT
BlackRock Institutional Trust
California
+$1.85M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$782K

Top Sellers

Rank Fund Capital Flow
1
First Eagle Investment Management
First Eagle Investment Management
New York
-$1M
2
PA
Perceptive Advisors
New York
-$736K
3
CS
Credit Suisse
Switzerland
-$710K
4
GPP
Great Point Partners
Connecticut
-$588K
5
U
UBS
Switzerland
-$520K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
76
Bank of Montreal
Ontario, Canada
$5K +$300 +17 +8%
BNP Paribas Financial Markets
77
BNP Paribas Financial Markets
France
$4.3K – – –
M&T Bank
78
M&T Bank
New York
$3K – – –
Creative Planning
79
Creative Planning
Kansas
$3K +$1.96K +111 +308%
CP
80
Corbenic Partners
Pennsylvania
$1K – – –
First Manhattan
81
First Manhattan
New York
$1K – – –
PSI
82
Pinnacle Summer Investments
Virginia
$1K – – –
BOK
83
Bank of Kentucky
Kentucky
$1K +$988 +56 New
BRWA
84
B. Riley Wealth Advisors
Florida
$87 +$88 +5 New
BG
85
BlackRock Group
United Kingdom
– -$389K -21,656 Closed
PAM
86
Panagora Asset Management
Massachusetts
– -$381K -21,230 Closed
SFM
87
Soros Fund Management
New York
– -$268K -14,933 Closed
LP
88
LMR Partners
United Kingdom
– -$183K -10,202 Closed
US Bancorp
89
US Bancorp
Minnesota
– -$112K -6,366 -100%
JP Morgan Chase
90
JP Morgan Chase
New York
– -$106K -5,918 Closed
CA
91
CapWealth Advisors
Tennessee
– -$4K -244 Closed
1 2 3
4

CASC Hedge Fund Activity: Q2 2014 in Review

86 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Cascadian Therapeutics, Inc. (CASC) for Q2 2014, worth a combined $131M — up 20% from $110M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new CASC positions and 6 closed out — a net gain of 12 holders — while 26 added to existing stakes and 26 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $4.59M. The largest seller was First Eagle Investment Management, cutting an estimated $1M.

  • 86 institutional investors held Cascadian Therapeutics, Inc. (CASC) as of Q2 2014, up from 74 in Q1 2014.
  • Funds reported $131M of Cascadian Therapeutics, Inc. stock for Q2 2014, up 20% quarter-over-quarter.
  • 18 funds opened new Cascadian Therapeutics, Inc. positions in Q2 2014 and 6 closed out, a net change of +12 holders.
  • The largest Cascadian Therapeutics, Inc. buyer in Q2 2014 was BlackRock Fund Advisors, an estimated $4.59M added.
  • The largest Cascadian Therapeutics, Inc. seller in Q2 2014 was First Eagle Investment Management, an estimated $1M sold.

Based on aggregated 13F filings for Q2 2014.